The end client supplied drug treatments for sufferers of both MS (Multiple Sclerosis) and RRMS (Relapsing-Remitting Multiple Sclerosis). They wanted to investigate the choices available when it comes to current treatment and to understand from a Neurology perspective the current approach to potential future treatments. They also wanted to understand issues such as efficacy, tolerability and safety of such treatments. This was a quick turnaround project with Neurologists across the US.
For the full case study please click below: